DUBAI, UAE, Dec. 20, 2023 /PRNewswire/ — “The era of global warming has ended, and the era of global boiling has arrived.” In July 2023, the UN Secretary-General Guterres sounded a new cautionary note of global warming. Against the backdrop of escalating climate crisis, the 28th Conference of the Parties (hereinafter referred to as COP28) under […]
WASHINGTON, Dec. 20, 2023 /PRNewswire/ — With the blessing of mobile electronic equipment, people are no longer restricted by complex environments and can become local anytime and anywhere, enjoying delicious food and beautiful scenery freely. How to continue to enjoy portability has become a big problem when going out: a small power bank cannot be charged […]
TAIPEI, Dec. 20, 2023 /PRNewswire/ — XING Technology, the holding company of Taiwan-based XING Mobility, an advanced battery technologies company founded in 2015, will be closing its Series B Equity Round led by Kubota Corporation (TYO: 6326, hereinafter “Kubota”), a leading manufacturer of agricultural and industrial machinery, by the end of 2023. This strategic investment […]
NANJING, China, Dec. 20, 2023 /PRNewswire/ — InxMed, a clinical-stage biotechnology company dedicates on developing innovative therapies against drug resistance, and Escugen, a clinical-stage antibody–drug conjugate (ADC) company, today announced that InxMed licensed EZWi-Fit® linker-payload platform from Escugen for the development of the next generation tumor-associated antigens (TAAs) targeting ADCs. The license agreement provides InxMed with right to use EZWi-Fit® platform on […]
Hitachi Solutions has been previously named as a Leader in the 2021 IDC MarketScape for Asia/Pacific Microsoft Dynamics 365 Implementation Services SINGAPORE, Dec. 20, 2023 /PRNewswire/ — Hitachi Solutions Asia Pacific, leading provider of industry solutions based on Microsoft platform, is delighted to announce its position in the Leaders Category on the IDC MarketScape: Asia/Pacific […]
BEIJING, Dec. 20, 2023 /PRNewswire/ — A news report from China’s Diplomacy in the New Era (chinadiplomacy.org.cn): The 2023 forum on “Benefiting All Mankind: Dialogue with the Silk Road” was convened in Beijing on Dec. 6, 2023 with a combination of online and offline participation. The 2023 forum on “Benefiting All Mankind: Dialogue with the […]
Collective effort to optimize and standardize treatment practices now covers more than 90% of adult cancer incidences plus an increasing number of pediatric diseases. PLYMOUTH MEETING, Pa., Dec. 20, 2023 /PRNewswire/ — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading academic cancer centers in the United States—is celebrating six years of working alongside the […]
BOSTON and HANGZHOU and SHANGHAI, China, Dec. 20, 2023 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as ‘Lynk Pharmaceuticals’), an innovative clinical stage company, announced that it has dosed the first patient with Rheumatoid Arthritis (RA) in a Phase Ⅲ clinical trial of its highly selective JAK1 inhibitor LNK01001. The clinical study is a […]